- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.01. | UCB, Novo Nordisk, Gilead rank highest among pharmas for HCP customer experience - survey | ||
| 27.01. | Novavax gets ready to take another shot at Covid vaccine market with next season plans | ||
| 27.01. | Post-hoc analysis: EMA's CHMP rejects Ipsen's potential drug for rare genetic disease | ||
| 27.01. | FDA approves another indication for Keytruda, this time in the adjuvant NSCLC setting | ||
| 27.01. | BridgeBio company sells off rare disease candidate to Galderma partner | ||
| 27.01. | Four years in, Sana gets first FDA go-ahead to bring cancer treatment into the clinic | ||
| 27.01. | J&J, Legend say Carvykti beat standard therapy in earlier-line blood cancer | ||
| 27.01. | Dutch biotech starts liquidation after ending PhIII in GVHD | ||
| 27.01. | Pfizer lays off employees at California and Connecticut sites | ||
| 27.01. | JPM23: BeiGene CEO John Oyler on the company's big ambitions | ||
| 27.01. | Celularity warns of looming layoffs, spotlights early programs as money runs dry | ||
| 27.01. | F-star gets down to the wire with $161M sale to Chinese buyer as national security concerns linger | ||
| 27.01. | Exclusive: Cell therapy biotech brings on Loxo vet amid global expansion plans; Retirement beckons for Vir's George Scangos | ||
| 27.01. | FDA advisory committee votes unanimously in favor of bivalent Covid shots replacing primary series | ||
| 26.01. | FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study | ||
| 26.01. | In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable' | ||
| 26.01. | 'Tis the season: GSK addresses winter virus surges with celebrity and influencer vaccine awareness campaigns | ||
| 26.01. | Bristol Myers claims win with CAR-T therapy Breyanzi in leukemia | ||
| 26.01. | FDA cuts off use for AstraZeneca's Covid-19 therapy Evusheld | ||
| 26.01. | FDA takes next step in Torrent Pharmaceuticals' troubled India plant saga, issues OAI | ||
| 26.01. | Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry | ||
| 26.01. | Evotec inks license agreement with J&J; Oncolytic virus biotech prices $15M IPO | ||
| 26.01. | Exclusive: Profluent debuts to design proteins with machine learning in bid to move past 'AI sprinkled on top' | ||
| 26.01. | Investor 'misalignment' leads to tRNA biotech's shuttering | ||
| 26.01. | Aridis' monoclonal antibody fails PhIII, but plans for second trial anyway |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
